ChemicalBook Product Catalog Analytical Chemistry Standard Pharmaceutical Impurity Reference Standards Tofacitinib Impurity 45

Tofacitinib Impurity 45

Tofacitinib Impurity 45 Basic information
Product Name:Tofacitinib Impurity 45
Synonyms:Tofacitinib Impurity 45;CP-690550 N-Hydroxyl;(3R,4R)-3-[(7-Hydroxy-7H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-1-piperidinepropanenitrile;Tofacitinib Impurity 172;1-Piperidinepropanenitrile, 3-[(7-hydroxy-7H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-
CAS:2407039-29-4
MF:C16H20N6O2
MW:328.38
EINECS:
Product Categories:
Mol File:2407039-29-4.mol
Tofacitinib Impurity 45 Structure
Tofacitinib Impurity 45 Chemical Properties
Melting point >144°C (dec.)
Boiling point 625.5±65.0 °C(Predicted)
density 1.39±0.1 g/cm3(Predicted)
storage temp. -20°C Freezer, Under inert atmosphere
solubility DMSO (Slightly), Methanol (Slightly, Sonicated)
pka6.04±0.60(Predicted)
form Solid
color Light Brown to Brown
Safety Information
MSDS Information
Tofacitinib Impurity 45 Usage And Synthesis
UsesCP-690550 N-Hydroxyl is an impurity of CP-690550 (C781350), a pyrrolo[2,3-d]pyrimidine derivative, as Janus kinase inhibitor for treatment of rheumatoid arthritis.
Tofacitinib Impurity 45 Preparation Products And Raw materials
N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine Tofacitinib Impurity 2 Tofacitinib Related Compound 1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORIDE (3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate Tofacitinib Impurity N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide 1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)- 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]- 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine Tofacitinib Impurity 36 Tofacitinib Impurity 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-
Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.